Activation of several receptors, including jt-opioid, a2-adrenergic, and neuropeptide Y receptors, inhibits excitatory nonadrenergic noncholinergic (NANC) neural responses in airways, which were mediated by the release of peptides from capsaicin-sensitive sensory nerves. This raises the possibility of a common inhibitory mechanism, which may be related to an increase in K+ conductance in sensory nerves. To examine this hypothesis, we have studied whether K+-channel blockers inhibit the effects of neuromodulators of sensory nerves in guinea pig bronchi by using selective K+-channel blockers. Charybdotoxin (ChTX; 10 nM), which blocks large conductance Ca2+-activated K+-channel function, completely blocked and reversed the inhibitory effects of a jA-opioid agonist, neuropeptide Y. and an a2-adrenoceptor agonist on excitatory NANC responses. Neither inhibitors of ATP-sensitive K+ channels (BRL 31660 or glibenclamide, both at 10 bsM) nor an inhibitor ofsmall conductance Ca2+-activated K+ channels (apamin; 0.1 ,M) were effective. This suggests that ChTX-sensitive K+-channel activation may be a common mechanism for the prejunctional modulation of sensory nerves in airways. This may have important implications for the control of neurogenic inflammation.
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Electrical field stimulation (EFS) elicits excitatory nonadrenergic noncholinergic (e-NANC) neural bronchoconstrictor responses in guinea pig airways, which are mediated by the release of tachykinins from unmyelinated sensory nerves (1) . This e-NANC response has been shown to be inhibited at a prejunctional level by the activation of several receptors such as ,-opioid (2-5), a2-adrenergic (6), y-aminobutyric acid type B (7), histamine H3 (8) , neuropeptide Y (NPY) (9, 10) , galanin (11) , adenosine A2 (12) , and 232-adrenergic (13) receptors. The mechanism by which prejunctional receptor activation leads to inhibition of neuropeptide release is unclear, and the presence of so many inhibitory prejunctional receptors on sensory nerves suggests that there may be a common molecular mechanism of action (14) . In the central nervous system, some of these agonists inhibit neuronal function by opening a common K+ channel (15, 16) , raising the possibility that a similar mechanism may operate in peripheral nerves. Cromakalim, an activator of ATP-sensitive K+ channel (KATP) (17, 18) , is indeed able to inhibit e-NANC responses and this effect is blocked by glibenclamide (19) , suggesting that a KA2TP is involved. Another K+-channel blocker, charybdotoxin (ChTX), extracted from the venom of the scorpion Lejurus quinquestriatus var. habraeus, has been shown to block large conductance Ca2+-activated K+ channels (Kca) in various tissues, including nerves (20) (21) (22) (23) . Furthermore, a K+ channel cloned from a hippocampal neuronal library is sensitive to ChTX (24) . In this study, we examined whether ChTX inhibited the neuromodulatory action of the g-opioid agonist [D-Ala2,N-MePhe4,Gly-o15]enkephalin (DAMGO), the a2-agonist clonidine, and NPY on e-NANC responses in guinea pig bronchi in vitro. These agonists were chosen as they do not have direct effects on airway smooth muscle tone. We also examined effects of other K'-channel blockers such as apamin, a protein extracted from bee venom and a blocker of small conductance K'a (25) , and BRL 31660 and glibenclamide, blockers of KATP (26, 27) 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. effects of DAMGO, clonidine, or NPY (all at 0.1 ,uM, which has previously been found to have a significant inhibitory effect) on e-NANC responses were examined in the presence or absence of ChTX (10 nM), using an incubation time of 20 min, which had previously been shown to give maximal inhibition. Effects of additional concentrations of ChTX (1 and 30 nM) on DAMGO-induced inhibitory modulation of e-NANC responses were also examined. In other experiments, reversal of the modulatory effects of the agonists on e-NANC responses after the addition of ChTX was examined. The effects of the opioid antagonist naloxone (1 ,M) on the modulatory responses to DAMGO and the a2 antagonist idazoxan (1 ,uM) on the response to clonidine confirmed that opioid and a2-receptors were involved, respectively. In this series of experiments, we also confirmed by using matched control tissues that modulatory effects of DAMGO, clonidine, and NPY persisted for the duration of the experiment.
We also studied the effect ofthe active trans enantiomer of cromakalim [the (-)-3S, 4R 
RESULTS
In the presence of atropine and propranolol (both at 1 I.M),
EFS ofguinea pig bronchial rings gave reproducible e-NANC bronchoconstrictor responses (Fig. 2) , which were inhibited by tetrodotoxin. DAMGO, clonidine, and NPY (all at 0.1 ,uM) attenuated the EFS-induced e-NANC response by 52.6% ± 7%, 54.3% ± 8%, and 25.3% ± 2%, respectively (n = 7; Fig. 3 ). ChTX (10 nM) alone had no effect on e-NANC responses (Fig. 2a) but prevented the inhibition of e-NANC responses by DAMGO (Fig. 2b) , clonidine, and NPY and also completely reversed the inhibition induced by these three compounds ( Fig. 2 c-e) . In the presence ofChTX (10 nM), the agonists did not show any significant inhibitory nerve modulation (Fig. 3) . However, ChTX (1 nM) had no significant effect on the modulation of e-NANC responses by DAMGO; inhibitions of e-NANC responses by DAMGO in the presence of 1, 10, and 30 nM were 45.9% ± 9.6% (n = 3; P > 0.05), 5.8% ± 4.5% (n = 7; P < 0.005), and 4.4% ± 3.4% (n = 5; P < 0.005), respectively (Fig. 4) . The KATP activator BRL 38227 (1 ,uM) produced a 68.0% ± 8.3% (n = 7) inhibition of the e-NANC response and this attenuation was completely inhibited and reversed by BRL onstrates that KLTP are not involved in inhibitory neural modulation by agonists such as A-opioids, a2-agonists, and NPY. The presence of apamin-sensitive K+ channels (small conductance Ka) in nerves has also been reported (30) . The fact that apamin at a relevant concentration failed to reverse the inhibitory modulation of DAMGO on e-NANC responses indicates that small conductance K&a are not involved in this common mechanism of inhibitory modulation.
We chose to examine those agonists that have previously been found to inhibit e-NANC responses in guinea pig bronchi without any effect on airway smooth muscle responses, so that an effect on sensory nerves was not in doubt (2) (3) (4) (5) 9) . Recently, opioids have been shown to directly
inhibit release of substance P from airway sensory nerves (31) . None of these agonists had any effect on substance log [Substance P (M)] P-induced bronchoconstriction, and ChTX was also without effect on airway smooth muscle contraction. oncentration-response curves constructed to exogeSensory neuropeptides in airways mimic many of the r circles) of ChTX (10 M) in tguresence (spolid Circles) and pathological features of bronchial asthma, including airway epresents a mean value ± SEM from seven animals.
smooth muscle contraction, edema, mucus hypersecretion, boline.
and plasma extravasation (32) , and there is circumstantial evidence that they may contribute to inflammation in asthagonists does not occur through the activation of matic airways (33) . A common mechanism of prejunctional KATP on sensory nerves.
inhibition of sensory nerves may therefore be of potential 0.1 AuM) was also without effect on the inhibition therapeutic importance in diseases such as asthma and rhinresponses induced by DAMGO (Fig. 5e) .
itis, where the exaggerated effects of sensory neuropeptides duced inhibition of e-NANC responses in the released via an axon reflex mechanism have been implicated apamin was 49.8% ± 8.3% (n = 5), which was not (14) . Moreover, the observation obtained in the present study V different from that without apamin (P > 0.05).
may be relevant to other sensory nerves outside the respinM) had no effect on the concentration-response ratory tract. Substance P, which is one of the sensory constructed to exogenous substance P ( (36, 37) . The demonstration of a fects of a ,u-opioid, a2-agonist, and NPY on common intracellular mechanism for inhibition of neuropep7onchoconstriction, suggesting that, at least in the tide release from sensory nerves may therefore have thera--eiunctional inhibition of the e-NANC resnonse peutic implications for a variety of human diseases.
following prejunctional receptor occupation on sensory nerves is achieved through the coupling of prejunctional receptors to a common ChTX-sensitive K+ channel. This report demonstrates the presence of a common pathway in inhibitory modulation of peripheral sensory nerves. It has been reported that in the central nervous system the stimulation of more than two receptors coexisting on the same neuron causes an increase in K+ conductance through the common intracellular mechanism (15, 16) . The present study provides functional evidence that the activation of a large conductance K'a is involved in inhibitory modulation of sensory nerves. ChTX is a relatively selective antagonist of large conductance K&a (20) , but it might have additional effects on other channels. A neuronal K+ channel that is sensitive to ChTX has been cloned and is presumably the channel relevant to the neuromodulatory effects described here (24) .
It has been reported that the KATP channel opener cromakalim inhibits e-NANC responses prejunctionally in vivo in guinea pigs (19) . We have now confirmed this in vitro by using the active enantiomer of cromakalim, BRL 38227 (lemakalim). This inhibitory effect of BRL 38227 was completely blocked by the K'TP antagonist glibenclamide (27) and BRL 31660(26), indicating that KATP are able to modulate e-NANC responses. However, the present study also dem- 
